Israeli startups Collplant and Stratasys have commenced a pre-clinical study to test the ability of their 3D-printed implants (see here previously) to promote the growth of natural tissue and completely degrade over time. It may be an alternative to reconstructive … Continue reading →

Israeli startups Stratasys (see here previously) and CollPlant (see here previously) are jointly to create human tissues and organs. They will use Stratasys’ P3 bioprinter and CollPlant’s rh-Collagen-based bioinks. The first project will be to produce reconstructive implants. https://ir.collplant.com/news-events/press-releases/detail/144/stratasys-and-collplant-unite-technologies-to-transform

Scientists at Israel’s Technion Institute have succeeded in 3D printing a network of blood vessels that can provide blood to implanted tissues. The collagen used in the printing process was derived from tobacco plants and made by Israel’s Collplant. https://www.jpost.com/science/the-future-of-personalized-medicine-technion-team-built-blood-tree-from-scratch-679872 … Continue reading →

Good article about Israel’s Collplant (reported here previously) and its technology that turns tobacco leaves into bio-ink for printing human organs. Collplant, together with United Therapeutics Corporation have already made lung parts and will now start working on printing replacement … Continue reading →

Israel’s CollPlant is partnering with US-based 3D Systems to spur breakthroughs in regenerative medicine. It brings together top 3D-printing technology with Collprint’s bioink technology for 3D bioprinting of tissues and organs. https://ir.collplant.com/press-releases/detail/83/3d-systems-and-collplant-biotechnologies-join-forces-to https://www.3dsystems.com/press-releases/3d-systems-and-collplant-biotechnologies-join-forces-accelerate-breakthroughs

Israel’s CollPlant has licensed US’s United Therapeutics to use CollPlant’s 3D bio-printing technology to manufacture lung transplants. The multi-million-dollar agreement can be expanded to print up to three additional organs. CollPlant will initially supply the necessary bio-ink https://ir.collplant.com/press-releases/detail/54/collplant-and-united-therapeutics-announce-global-licensing

Israel’s CollPlant (see here) is developing a proprietary rhCollagen-based formulations intended for use as bio-ink for the 3D printing of tissues and life savings organs.  It has now received grant approval (up to $1.2 million) of additional finance from the … Continue reading →

I’ve reported previously (see here) on Israel’s Collplant and its proprietary plant-based technology to produce rhCollagen (recombinant human collagen). CollPlant has just opened a new facility in Rehovot, for producing rhCollagen to make tissue repair products and 3D printing of … Continue reading →